Your Article Summary
A Live-Attenuated Vaccine for the Treatment of Urinary Tract Infection by Uropathogenic Escherichia coli
The Journal of Infectious Diseases, 06/19/09
Billips BK et al. - NU14 delta-waaL is a candidate live-attenuated vaccine for the treatment and prevention of acute and recurrent urinary tract infection by caused by uropathogenic E. coli.
Today in Nephrology/Urology...keeping you current
Receive free subspecialty "5-minute updates" via email
Tubular Toxicity in Sirolimus- and Cyclosporine-Based Transplant Immunosuppression Strategies: An Ancillary Study From a Randomized Controlled Trial
American Journal of Kidney Diseases, 11/19/09
The Alphabet Soup of Kidney Transplantation: SCD, DCD, ECD—Fundamentals for the Practicing Nephrologist
Clinical Journal of the American Society of Nephrology, 11/16/09
Immune Responses in Patients with Metastatic Renal Cell Carcinoma Treated with Dendritic Cells Pulsed with Tumor Lysate
Scandinavian Journal of Immunology, 11/02/09
Today in Vaccine/Immunotherapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Update on vaccination guidelines for allergic children
Expert Review of Vaccines, 10/29/09
Safety of vaccination of patients with systemic lupus erythematosus
Lupus, 11/04/09
Yearly influenza vaccinations: a double-edged sword
The Lancet Infectious Diseases, 11/19/09

See Latest Articles